Dr. Burger on the Benefits of Novel Combination Approaches in CLL
Jan A. Burger, MD, PhD, discusses the benefit of combination therapy in patients with chronic lymphocytic leukemia. Jan A. Burger, MD, PhD, tenured professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center,...
www.onclive.com
Comments / 0